Highlights from the journal CHEST®, April 2023

Glenview, Illinois – Published monthly, the journal CHEST^® features peer-reviewed, cutting-edge original research in chest medicine: Pulmonary, critical care and sleep medicine and related disciplines. Journal topics include asthma, chest infections, COPD, critical care, diffuse lung disease, education and clinical practice, pulmonary vascular disease, sleep, thoracic oncology and the humanities.

The April issue of the CHEST journal contains 50 articles, including clinically relevant research, reviews, case series, commentary and more. Each month, the journal also offers complementary web and multimedia resources, including visual abstracts, to expand the reach of its most interesting, timely and relevant research.

“With April serving as Sarcoidosis Awareness Month, I recommend reading the latest research, “Efzofitimod for the Treatment of Pulmonary Sarcoidosis,” included in the April issue,” says Editor in Chief of the journal, Peter Mazzone, MD, MPH, FCCP. “While larger studies are needed, this research suggests that efzofitimod may be a useful treatment to manage sarcoidosis.”

Also included in the current issue of the journal CHEST:

• Asthma
  Cross-sectional study, “Peripheral Airway Dysfunction in Obesity and Obese Asthma,” finds that people with obesity and asthma have significant dysfunction in the distal airways at baseline that worsens with methacholine.
• Critical Care
  Qualitative analysis, “Multidisciplinary ICU Recovery Clinic Visits,” identifies two primary themes from the patient-provider dialogue: problem identification and problem-solving strategies. View the visual abstract for this research.
• Sleep
  Original research, “OSA and Subsequent Risk of Hospitalization With Pneumonia, RespiratoryInfection, and Total Infection,” suggests screening for and treating severe OSA in the primary care setting may lower the risk of hospitalization caused by pneumonia and other infectious diseases. View the visual abstract for this research.
• Thoracic Oncology
  “Shape-Sensing Robotic-Assisted Bronchoscopy vs Digital Tomosynthesis-Corrected Electromagnetic Navigation Bronchoscopy” uses a uniform conservative definition of diagnostic yield to show that diagnostic performance and safety profiles were comparable for shape-sensing robotic-assisted bronchoscopy and digital tomosynthesis-electromagnetic navigational bronchoscopy. Listen to a podcast of the experts discussing their findings.

To view the entire April issue of the CHEST journal, visit journal.chestnet.org, and follow @journal_CHEST on Twitter for the latest journal news.

About the American College of Chest Physicians

The American College of Chest Physicians^® (CHEST) is the global leader in the prevention, diagnosis and treatment of chest diseases. Its mission is to champion advanced clinical practice, education, communication and research in chest medicine. It serves as an essential connection to clinical knowledge and resources for its 19,000+ members from around the world who provide patient care in pulmonary, critical care and sleep medicine. For information about the American College of Chest Physicians, and its flagship journal CHEST^®, visit chestnet.org.